Healthcare provider profile · identity verified

Jorge Soto, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · AGUADA, PR · NPI 1497977227

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jorge Soto, M.D. received $101.68 in general payments during 2025 across 5 reported records.

AstraZeneca Pharmaceuticals LP accounted for 76.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Lumigan by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 753 claims for Synthroid by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 403 claims for Farxiga by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$101.68

5 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$77.42	76.1%	4	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$24.26	23.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$101.68	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
AVYCAZ Normalized: avycaz	Drug	ABBVIE INC.	$24.26	1	2025
Source payment records 2025-07-07 · ABBVIE INC. · $24.26 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	19	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LUMIGAN open payments reported associated product	CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548	Lumigan · 2024 Exact normalized brand match · 1 Part D row	21	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	753	90
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	40	23
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	403	72

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	1657	201
Famotidine	Famotidine	1386	195
Atorvastatin Calcium	Atorvastatin Calcium	1348	333
Levothyroxine Sodium	Levothyroxine Sodium	980	127
Rosuvastatin Calcium	Rosuvastatin Calcium	874	238
Clonazepam	Clonazepam	788	90
Synthroid	Levothyroxine Sodium	753	90
Losartan Potassium	Losartan Potassium	637	177
Tamsulosin Hcl	Tamsulosin Hcl	623	94
Pantoprazole Sodium	Pantoprazole Sodium	592	89
Lisinopril	Lisinopril	585	155
Omeprazole	Omeprazole	489	56
Glimepiride	Glimepiride	476	116
Metformin Hcl	Metformin Hcl	444	121
Alendronate Sodium	Alendronate Sodium	433	61
Farxiga	Dapagliflozin Propanediol	403	72
Metoprolol Succinate	Metoprolol Succinate	373	125
Montelukast Sodium	Montelukast Sodium	324	46
Amlodipine Besylate	Amlodipine Besylate	322	83
Temazepam	Temazepam	322	42
Sertraline Hcl	Sertraline Hcl	316	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	315	84
Clopidogrel	Clopidogrel Bisulfate	304	76
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	290	57
Lantus	Insulin Glargine,hum.Rec.Anlog	288	35
Xigduo Xr	Dapaglifloz Propaned/Metformin	275	37
Carvedilol	Carvedilol	269	79
Fluoxetine Hcl	Fluoxetine Hcl	254	31
Donepezil Hcl	Donepezil Hcl	231	38
Ezetimibe	Ezetimibe	212	44
Simvastatin	Simvastatin	205	53
Enalapril Maleate	Enalapril Maleate	203	47
Trijardy Xr	Empaglifloz/Linaglip/Metformin	190	30
Trazodone Hcl	Trazodone Hcl	184	28
Fluticasone Propionate	Fluticasone Propionate	177	40
Nabumetone	Nabumetone	170	39
Xarelto	Rivaroxaban	170	36
Alprazolam	Alprazolam	168	22
Bumetanide	Bumetanide	166	30
Dexamethasone	Dexamethasone	157	118
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	156	74
Spironolactone	Spironolactone	156	47
Diclofenac Sodium	Diclofenac Sodium	154	37
Doxazosin Mesylate	Doxazosin Mesylate	153	41
Finasteride	Finasteride	153	28
Buspirone Hcl	Buspirone Hcl	151	24
Escitalopram Oxalate	Escitalopram Oxalate	151	21
Tolterodine Tartrate Er	Tolterodine Tartrate	150	24
Tizanidine Hcl	Tizanidine Hcl	148	41
Isosorbide Mononitrate Er	Isosorbide Mononitrate	143	41
Meloxicam	Meloxicam	141	53
Quetiapine Fumarate	Quetiapine Fumarate	141	17
Lansoprazole	Lansoprazole	140	22
Eliquis	Apixaban	138	34
Mirtazapine	Mirtazapine	137	25
Fenofibrate	Fenofibrate Nanocrystallized	135	29
Furosemide	Furosemide	130	38
Duloxetine Hcl	Duloxetine Hcl	128	12
Albuterol Sulfate Hfa	Albuterol Sulfate	122	30
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	120	14
Allopurinol	Allopurinol	117	15
Irbesartan	Irbesartan	107	22
Metoprolol Tartrate	Metoprolol Tartrate	105	31
Lorazepam	Lorazepam	103	16
Estazolam	Estazolam	94	15
Prednisone	Prednisone	94	18
Cilostazol	Cilostazol	93	suppressed
Humalog	Insulin Lispro	93	11
Warfarin Sodium	Warfarin Sodium	87	suppressed
Raloxifene Hcl	Raloxifene Hcl	86	11
Etodolac	Etodolac	85	36
Hydrochlorothiazide	Hydrochlorothiazide	84	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	82	69
Bupropion Xl	Bupropion Hcl	81	11
Levoxyl	Levothyroxine Sodium	80	suppressed
Atenolol	Atenolol	79	17
Baclofen	Baclofen	78	15
Glyxambi	Empagliflozin/Linagliptin	76	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	20
Risperidone	Risperidone	75	11
Synjardy Xr	Empagliflozin/Metformin Hcl	74	14
Pravastatin Sodium	Pravastatin Sodium	73	12
Amitriptyline Hcl	Amitriptyline Hcl	72	suppressed
Sucralfate	Sucralfate	72	15
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	71	37
Citalopram Hbr	Citalopram Hydrobromide	70	suppressed
Hydralazine Hcl	Hydralazine Hcl	70	19
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	68	17
Esomeprazole Magnesium	Esomeprazole Magnesium	67	suppressed
Latanoprost	Latanoprost	66	11
Memantine Hcl	Memantine Hcl	66	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	64	17
Ibandronate Sodium	Ibandronate Sodium	63	suppressed
Metformin Hcl Er	Metformin Hcl	63	14
Ibuprofen	Ibuprofen	61	32
Synjardy	Empagliflozin/Metformin Hcl	61	16
Tramadol Hcl	Tramadol Hcl	60	18
Candesartan Cilexetil	Candesartan Cilexetil	58	18
Levetiracetam	Levetiracetam	58	suppressed
Levofloxacin	Levofloxacin	57	53
Nifedipine Er	Nifedipine	57	41
Diclofenac Potassium	Diclofenac Potassium	54	13
Azithromycin	Azithromycin	53	47
Doxepin Hcl	Doxepin Hcl	53	11
Fluconazole	Fluconazole	53	43
Celecoxib	Celecoxib	52	17
Naproxen	Naproxen	52	suppressed
Verapamil Er	Verapamil Hcl	52	12
Metoclopramide Hcl	Metoclopramide Hcl	50	suppressed
Glipizide	Glipizide	49	suppressed
Folic Acid	Folic Acid	48	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	48	suppressed
Propranolol Hcl	Propranolol Hcl	48	suppressed
Sulindac	Sulindac	48	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	46	45
Calcitriol	Calcitriol	42	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	42	suppressed
Jardiance	Empagliflozin	42	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	42	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Brilinta	Ticagrelor	40	23
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	40	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	15
Cholestyramine	Cholestyramine (With Sugar)	39	suppressed
Ozempic	Semaglutide	38	suppressed
Clobetasol Propionate	Clobetasol Propionate	37	suppressed
Ramipril	Ramipril	37	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	suppressed
Ciclopirox	Ciclopirox	36	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	32
Digoxin	Digoxin	34	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	33	20
Dexlansoprazole Dr	Dexlansoprazole	33	suppressed
Leflunomide	Leflunomide	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	27
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	suppressed
Pioglitazone-Metformin	Pioglitazone Hcl/Metformin Hcl	31	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	30	suppressed
Galantamine Hbr	Galantamine Hbr	30	suppressed
Humulin N	Insulin Nph Human Isophane	30	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	30	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Valsartan	Valsartan	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	28	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	27	suppressed
Mometasone Furoate	Mometasone Furoate	26	13
Sulfasalazine	Sulfasalazine	26	suppressed
Anastrozole	Anastrozole	25	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Insulin Glargine	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Letrozole	Letrozole	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Insulin Lispro	Insulin Lispro	24	suppressed
Risedronate Sodium	Risedronate Sodium	24	suppressed
Myrbetriq	Mirabegron	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Humulin R	Insulin Regular, Human	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	22	20
Nitroglycerin	Nitroglycerin	22	suppressed
Primidone	Primidone	22	suppressed
Procto-Med Hc	Hydrocortisone	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Lumigan	Bimatoprost	21	suppressed
Savella	Milnacipran Hcl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Ketoconazole	Ketoconazole	20	11
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	19	suppressed
Clotrimazole	Clotrimazole	19	15
Desloratadine	Desloratadine	19	suppressed
Linzess	Linaclotide	19	suppressed
Metronidazole	Metronidazole	19	18
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Advocate Syringes	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Desonide	Desonide	17	suppressed
Epinephrine	Epinephrine	17	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	17	13
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	17	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Progesterone	Progesterone, Micronized	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	15	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Jentadueto	Linagliptin/Metformin Hcl	14	suppressed
Methylprednisolone	Methylprednisolone	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Terconazole	Terconazole	14	12
Dilantin	Phenytoin Sodium Extended	13	suppressed
Estradiol	Estradiol	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	13	13
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	13	13
Levemir	Insulin Detemir	13	suppressed
Mesalamine Dr	Mesalamine	13	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Theophylline Er	Theophylline Anhydrous	13	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Trandolapril	Trandolapril	12	suppressed
Advocate Syringes	Syringe And Needle,insulin,1ml	11	suppressed
Cevimeline Hcl	Cevimeline Hcl	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Paroxetine Er	Paroxetine Hcl	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$101.68 · 5 records	AstraZeneca Pharmaceuticals LP	AVYCAZ	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error